Professional self-care and burnout prevention

The manuals converge strongly on the idea that professional self-care is part of competent practice in emotionally intense psychedelic therapy settings. Across the extracts, therapists are described as needing ongoing self-care, supervision, and some form of personal processing to reduce vicarious traumatization, compassion fatigue, and loss of effectiveness. They also consistently recommend debriefing with co-therapists or team members, using peer supervision, and attending to bodily signs of stress, including grounding, breathing, rest, nutrition, and recovery after demanding sessions. The sources also overlap in treating reflective practice and support systems as part of sustainable work. They mention continuing one’s own inner work or psychotherapy, processing emotional responses to participants’ trauma, and maintaining realistic expectations. In this sense, self-care is framed not as an optional extra, but as part of professional responsibility and clinical judgment. The main differences are in emphasis and wording rather than in overall direction. The MDMA manuals place stronger emphasis on inner work, ongoing psychotherapy, and reviewing team interactions to improve therapeutic teamwork and clinical judgment, while the psilocybin trial extract foregrounds compassion fatigue and restoring balance and clarity. The psilocybin source also explicitly mentions study team members alongside co-therapists in debriefing, whereas the MDMA extracts focus more on co-therapist debriefing, peer supervision, and supervision with another therapist.